Insider of issuer (NASDAQ: ARQQ) files to sell 3,000 shares
Rhea-AI Filing Summary
An insider of the issuer has filed a Form 144 notice to sell up to 3,000 shares of common stock through Fidelity Brokerage Services, with an approximate aggregate market value of $84,000.00. The proposed sale is expected around 01/06/2026 on the NASDAQ market.
The shares to be sold were acquired from the issuer via a stock option exercise of 1,882 shares paid in cash on 02/13/2025, and restricted stock vesting of 617 shares on 04/01/2025, 373 shares on 07/01/2025, and 128 shares on 10/01/2025 as compensation. In the past three months, seller Patrick Willcocks sold 1,419 shares for gross proceeds of $69,788.83 on 10/06/2025 and 1,913 shares for $43,735.77 on 01/02/2026.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing for ARQQ indicate?
This Form 144 indicates that an insider has given notice of intent to sell up to 3,000 shares of common stock of the issuer on the open market.
How many ARQQ shares are planned to be sold under this notice?
The notice covers a proposed sale of 3,000 shares of common stock, with an approximate aggregate market value of $84,000.00.
On which exchange and through which broker will the ARQQ shares be sold?
The planned sale is through Fidelity Brokerage Services LLC, with trading on the NASDAQ exchange.
How were the ARQQ shares being sold acquired by the insider?
The shares were acquired from the issuer via a stock option exercise of 1,882 shares paid in cash on 02/13/2025 and through restricted stock vesting of 617, 373, and 128 shares on 04/01/2025, 07/01/2025, and 10/01/2025 respectively, as compensation.
Who has recently sold ARQQ shares and in what amounts?
Patrick Willcocks, listed at 3 Orchard Place, London, sold 1,419 common shares on 10/06/2025 for gross proceeds of $69,788.83 and 1,913 common shares on 01/02/2026 for $43,735.77.
What does the Form 144 representation about material information mean for ARQQ?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Does the ARQQ Form 144 mention a Rule 10b5-1 trading plan?
The form states that if the person adopted a written trading plan or gave trading instructions under Rule 10b5-1, signing the form and indicating the adoption date would make the same representation as of that date.